Sanofi hosted an IR Thematic Seminar on New Medicines at the Genzyme Headquarters in Cambridge, MA.

The event focused on late-stage pipeline assets. The agenda consisted of several deep dive sessions on new medicines and vaccines that we expect to launch in 2015, such as alirocumab, Dengue vaccine, Toujeo® and Afrezza®. A high level update on the next wave of innovative medicines and vaccines was also provided.